Recent Company News

• 09:13 AM ET Jun 16, 2026
  

  Trinity Biotech reports Q1 net income ($4.4M) vs year-ago ($8.8M) ($0.68, 0.00)

• 04:24 PM ET Jun 12, 2026
  

  Trinity Biotech enters ATM sales agreement for up to $4.4M of ADSs with Lucid Capital Markets - 424B5 ($0.65, 0.00)

• 10:42 PM ET May 11, 2026
  

  Trinity Biotech Provides Business and Trading Update

• 09:30 PM ET May 11, 2026
  

  Trinity Biotech Advances Next-Generation CGM+ With Technical Breakthroughs

• 09:27 AM ET Mar 23, 2026
  

  Trinity Biotech announces clinical results for its enhanced EpiCapture prostate cancer test ($0.64, 0.00)

• 08:37 AM ET Mar 18, 2026
  

  Trinity Biotech announces collaboration with University at Buffalo to commercialize novel biomarkers for Sjögren's syndrome ($0.74, 0.00)

• 07:47 AM ET Mar 10, 2026
  

  Trinity Biotech guides Q4 revenue $11.5M-12.5M vs year-ago $15.9M ($0.70, 0.00)

• 09:04 AM ET Feb 25, 2026
  

  Trinity Biotech Secures enters $25M SEPA with Yorkville in support of growth initiatives; provides business update ($0.75, 0.00)

• 01:31 PM ET Feb 10, 2026
  

  Trinity Biotech secures regulatory approval for commencement of upstream manufacturing activities of Uni-Gold HIV rapid test ($0.91, +0.11)

• 08:53 AM ET Dec 23, 2025
  

  Trinity Biotech announces financing transactions with Perceptive Advisors ($0.89, 0.00)